Zytoprotec

Austria
Vienna, Vienna, Austria, 1090

Company profile

Zytoprotec company profile

Zytoprotec is an Austrian biotechnology company, founded in 2007 to apply ground-breaking findings in the area of cytoprotection to the development of new treatment options for major disease areas. The Company was founded by a team of professionals that combine extensive experience in business administration, clinical research, pharmaceutical product development, as well as company and patent law.

Business identity

Contact email
[email protected]
Phone number
+43 1 406 20 02
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2007-01-01, Year

Headquarters

Postal code
1090
Country code
AT
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$2.7M
Last funding
Series A / $2.7M / 2013-01-29
Last equity funding
Series A / $2.7M
Investors
1
Lead investors
1
Founders
1

Founders and investors

Founders

Christoph Aufricht

Lead investors

Baxter International

Investors

Baxter International